Literature DB >> 29605476

ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer.

Ursula Nestle1, Dirk De Ruysscher2, Umberto Ricardi3, Xavier Geets4, Jose Belderbos5, Christoph Pöttgen6, Rafal Dziadiuszko7, Stephanie Peeters8, Yolande Lievens9, Coen Hurkmans10, Ben Slotman11, Sara Ramella12, Corinne Faivre-Finn13, Fiona McDonald14, Farkhad Manapov15, Paul Martin Putora16, Cécile LePéchoux17, Paul Van Houtte18.   

Abstract

Radiotherapy (RT) plays a major role in the curative treatment of locally advanced non-small cell lung cancer (NSCLC). Therefore, the ACROP committee was asked by the ESTRO to provide recommendations on target volume delineation for standard clinical scenarios in definitive (chemo)radiotherapy (RT) and adjuvant RT for locally advanced NSCLC. The guidelines given here are a result of the evaluation of a structured questionnaire followed by a consensus discussion, voting and writing procedure within the committee. Hence, we provide advice for methods and time-points of diagnostics and imaging before the start of treatment planning and for the mandatory and optional imaging to be used for planning itself. Concerning target volumes, recommendations are given for GTV delineation of primary tumour and lymph nodes followed by issues related to the delineation of CTVs for definitive and adjuvant radiotherapy. In the context of PTV delineation, recommendations about the management of geometric uncertainties and target motion are given. We further provide our opinions on normal tissue delineation and organisational and responsibility questions in the process of target volume delineation. This guideline intends to contribute to the standardisation and optimisation of the process of RT treatment planning for clinical practice and prospective studies.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  NSCLC; Radiotherapy; Target volumes

Mesh:

Year:  2018        PMID: 29605476     DOI: 10.1016/j.radonc.2018.02.023

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  42 in total

Review 1.  [Clinical target volume : Principles and limits].

Authors:  T B Brunner; M Walke; P Hass
Journal:  Radiologe       Date:  2018-08       Impact factor: 0.635

Review 2.  Imaging for Target Delineation and Treatment Planning in Radiation Oncology: Current and Emerging Techniques.

Authors:  Sonja Stieb; Brigid McDonald; Mary Gronberg; Grete May Engeseth; Renjie He; Clifton David Fuller
Journal:  Hematol Oncol Clin North Am       Date:  2019-09-17       Impact factor: 3.722

Review 3.  [Gross tumor volume (GTV) : Basics, methods, registration, limitations].

Authors:  C Thieke
Journal:  Radiologe       Date:  2018-08       Impact factor: 0.635

4.  Software simulation of tumour motion dose effects during flattened and unflattened ITV-based VMAT lung SBRT.

Authors:  Marta Adamczyk; Marta Kruszyna-Mochalska; Anna Rucińska; Tomasz Piotrowski
Journal:  Rep Pract Oncol Radiother       Date:  2020-06-11

Review 5.  Challenges in the target volume definition of lung cancer radiotherapy.

Authors:  Susan Mercieca; José S A Belderbos; Marcel van Herk
Journal:  Transl Lung Cancer Res       Date:  2021-04

6.  Impact of EBUS-TBNA in addition to [18F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC.

Authors:  Maja Guberina; Kaid Darwiche; Hubertus Hautzel; Till Ploenes; Christoph Pöttgen; Nika Guberina; Ken Herrmann; Lale Umutlu; Axel Wetter; Dirk Theegarten; Clemens Aigner; Wilfried Ernst Erich Eberhardt; Martin Schuler; Rüdiger Karpf-Wissel; Martin Stuschke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-05       Impact factor: 9.236

Review 7.  Value of PET imaging for radiation therapy.

Authors:  Constantin Lapa; Ursula Nestle; Nathalie L Albert; Christian Baues; Ambros Beer; Andreas Buck; Volker Budach; Rebecca Bütof; Stephanie E Combs; Thorsten Derlin; Matthias Eiber; Wolfgang P Fendler; Christian Furth; Cihan Gani; Eleni Gkika; Anca-L Grosu; Christoph Henkenberens; Harun Ilhan; Steffen Löck; Simone Marnitz-Schulze; Matthias Miederer; Michael Mix; Nils H Nicolay; Maximilian Niyazi; Christoph Pöttgen; Claus M Rödel; Imke Schatka; Sarah M Schwarzenboeck; Andrei S Todica; Wolfgang Weber; Simone Wegen; Thomas Wiegel; Constantinos Zamboglou; Daniel Zips; Klaus Zöphel; Sebastian Zschaeck; Daniela Thorwarth; Esther G C Troost
Journal:  Strahlenther Onkol       Date:  2021-07-14       Impact factor: 3.621

8.  18F-fluorothymidine (FLT)-PET and diffusion-weighted MRI for early response evaluation in patients with small cell lung cancer: a pilot study.

Authors:  Tine Nøhr Christensen; Seppo W Langer; Katrine Engholm Villumsen; Helle Hjorth Johannesen; Johan Löfgren; Sune Høgild Keller; Adam Espe Hansen; Andreas Kjaer; Barbara Malene Fischer
Journal:  Eur J Hybrid Imaging       Date:  2020-01-27

9.  Radiotherapy Planning and Molecular Imaging in Lung Cancer.

Authors:  Angelina Filice; Massimiliano Casali; Patrizia Ciammella; Marco Galaverni; Federica Fioroni; Cinzia Iotti; Annibale Versari
Journal:  Curr Radiopharm       Date:  2020

10.  Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist.

Authors:  Yongjie Yang; Jingli Lu; Yanfang Ma; Chen Xi; Jian Kang; Qiwen Zhang; Xuedong Jia; Kefeng Liu; Shuzhang Du; Florian Kocher; Andreas Seeber; Cesare Gridelli; Mariano Provencio; Nobuhiko Seki; Yusuke Tomita; Xiaojian Zhang
Journal:  Transl Lung Cancer Res       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.